10 results
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
for VTE in Malignancy ... thrombosis in cancer ... #DOAC #VTE #Malignancy ... Anticoagulation #Management ... #Hematology #Oncology
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
algorithm for the treatment ... of cancer-associated ... #DOAC #VTE #Malignancy ... Anticoagulation #Management ... #Hematology #Oncology
Hodgkin's Lymphoma Overview

Hodgkin's lymphoma (HL) is an uncommon hematological malignancy arising from mature B cells. It
hematological malignancy ... from germinal center ... Treatment • Early ... classification #hematology ... #oncology #management
Tumor Lysis Syndrome
An acute, life-threatening condition that appears within 7 days of starting cytotoxic therapies in
chemosensitive malignancy ... like Burkitt's lymphoma ... Walid Malki, MD, MS ... Syndrome #TLS #oncology ... #management #UricAcid
Sweet Syndrome

Acute febrile neutrophilic dermatosis (Sweets Syndrome) is a skin condition characterized by fever and inflamed
(malignancy), lymphoma ... , breast CA - Hematologic ... cancer such as ... Treatment: - Systemic ... #oncology
Hemophagocytic Lymphohistiocytosis (HLH)
Pathophysiology: Triggering factor (infection,...)→Activation of CD8 T cells (IFN-y) → Excessive activation of macrophages
Lymphohistiocytosis (HLH) Pathophysiology ... , B-cell lymphoma ... B-LNH), solid cancers ... Lymphohistiocytosis #diagnosis #management ... #rheumatology
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
Nephrogenic DI Hematologic ... phenomenon (16%) MSK ... and Arthritis Malignancy ... Adenocarcinoma Treatment ... #Diagnosis #Management
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
tuberculosis (LTBI) Pathophysiology ... Sarcoidosis • Lymphoma ... • Lung cancer ... tracheobronchial stenosis, malignancy ... TB #Diagnosis #Management
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
tuberculosis (LTBI) Pathophysiology ... Sarcoidosis • Lymphoma ... • Lung cancer ... tracheobronchial stenosis, malignancy ... TB #Diagnosis #Management
Hemophagocytic Lymphohistiocytosis (HLH)

High mortality without prompt recognition and management. HLH is a critical diagnostic consideration in
recognition and management ... it is often a cancer ... Pathophysiology ... trigger: Infections, malignancy ... #Hematology #HemeOnc